fincash logo SOLUTIONS

Fincash » Search » Dr Reddy's Laboratories Ltd

Dr Reddy s Laboratories Ltd

Updated on August 3, 2020

Stock/Share Code - DRREDDY

Dr Reddys Laboratories is a leading India-based pharmaceutical company headquartered and having its registered offi ce in Hyderabad, Telangana, India. Through its three businesses - Pharmaceutical more

Below is the details of DRREDDY Dr Reddy s Laboratories Ltd

Market Cap₹67,653 Cr.
Current Price ₹4,573.5 as on 7 Aug 20
52 Week High / Low Price₹4,132.2 / ₹2,351.2
Face Value₹5
Stock P/E23.03
Book Value₹914.23
Dividend Yield0.49 %
ROCE11.86 %
ROE9.89 %
Sales Growth (3yrs)1.07 %
IndustryPharmaceuticals - Indian - Bulk Drugs & Formln
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company has reduced debt. Company is virtually debt free. Company has been maintaining a healthy dividend payout of 36.17%
Cons: Stock is trading at 4.45 times its book value The company has delivered a poor growth of 1.78% over past five years. Promoter holding is low: 26.82% Company has a low return on equity of 8.81% for last 3 years.

Dr Reddy s Laboratories Ltd Price Chart

Dr Reddy s Laboratories Ltd Price Chart

Dr Reddy s Laboratories Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Sun Pharma.Inds. ₹180.85 28.53 ₹113,788.46 Cr. 0.63 ₹399.84 Cr. -2.03 14.25 8184.94 11.19
2. Dr Reddy's Labs 23.03 ₹67,652.81 Cr. 0.49 ₹502.8 Cr. 147.93 7.81 2851.70 11.86
3. Cipla ₹728.65 33.79 ₹52,256.4 Cr. 0.46 ₹245.95 Cr. -33.02 -0.63 4376.19 10.94
4. Aurobindo Pharma ₹906.45 16.67 ₹43,690.51 Cr. 0.40 ₹705.45 Cr. -2.26 11.87 5895.00 18.45
5. Biocon ₹399.45 62.53 ₹42,564 Cr. 0.14 ₹123.4 Cr. -42.26 3.41 1581.00 13.39
6. Torrent Pharma. ₹46.15 39.00 ₹39,979.07 Cr. 0.72 ₹314 Cr. 121.13 4.85 1946.00 12.66
7. Cadila Health. ₹390.9 25.02 ₹35,278.17 Cr. 1.02 ₹373.9 Cr. -26.54 1.68 3638.10 15.35
8. Alkem Lab ₹2,981.95 24.26 ₹27,056.36 Cr. 0.97 ₹381.98 Cr. 88.60 13.26 2181.84 16.58

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Dr Reddy s Laboratories Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020
Sales -2,0902,2542,5232,4922,6182,6312,7322,6452,5093,4463,0442,852
YOY Sales Growth %-3.42%-14.20%-1.77%5.60%25.26%16.71%8.27%6.13%-4.16%30.98%11.43%7.81%
Expenses -1,9411,9411,9882,1662,0432,0662,0452,2092,0782,2852,2882,331
Material Cost %27.41%29.35%25.64%30.08%26.25%26.84%28.50%32.74%30.47%27.36%30.19%33.23%
Employee Cost %21.56%20.07%18.89%18.59%17.84%19.12%17.27%18.52%19.91%14.59%16.79%18.12%
Operating Profit1483145363265755656874374311,161756521
OPM %7%14%21%13%22%21%25%17%17%34%25%18%
Other Income49404873357593734717769127
Profit before tax-101403721964014335702966931,021618444
Tax %28%28%20%10%18%20%30%32%21%-34%16%-13%
Net Profit-71012971773293463992035481,365522503
EPS in Rs-0.446.0717.9010.6519.8220.8624.0812.2233.0682.3631.4730.24

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019TTM
Sales -3,3654,1594,5125,2436,7408,3709,72810,01110,2929,7209,35910,62611,850
Sales Growth %-14.93%23.59%8.50%16.19%28.55%24.20%16.22%2.91%2.81%-5.56%-3.71%13.53%
Expenses -2,7953,3093,4014,0525,1926,3856,9667,6208,2277,9498,0298,3268,982
Material Cost %31.27%26.77%27.23%30.27%28.81%30.70%25.60%28.17%25.79%26.52%28.11%28.59%
Manufacturing Cost %13.48%14.41%12.75%7.93%7.97%6.95%10.98%11.44%11.97%13.23%14.47%10.21%
Employee Cost %10.88%9.92%11.44%13.40%12.93%13.67%14.68%14.97%16.53%18.63%19.76%18.26%
Other Cost %27.43%28.47%23.94%25.69%27.33%24.96%20.36%21.54%25.65%23.40%23.46%21.30%
Operating Profit5708501,1111,1901,5481,9862,7622,3912,0651,7711,3302,3002,868
OPM %17%20%25%23%23%24%28%24%20%18%14%22%24%
Other Income19110121211982142152223325566204238745
Profit before tax5847301,0851,0521,2591,7532,4542,0601,6771,5446971,7012,776
Tax %19%23%22%15%28%28%21%18%18%10%19%25%
Net Profit4755618468939121,2661,9331,6791,3741,3845671,2772,938
EPS in Rs27.6232.2548.2550.9851.5771.98113.5694.4880.5683.4834.1576.95177.13
Dividend Payout %13%19%22%21%26%20%16%20%25%24%59%26%

Compounded Sales Growth

  • 10 Years:: 9.83%
  • 5 Years:: 1.78%
  • 3 Years:: 1.07%
  • TTM:: 11.53%

Compounded Profit Growth

  • 10 Years:: 8.18%
  • 5 Years:: -8.83%
  • 3 Years:: -2.77%
  • TTM:: 129.99%

Return on Equity

  • 10 Years:: 11.22%
  • 5 Years:: 3.50%
  • 3 Years:: 16.81%
  • 1 Year:: 52.01%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -84848485858585858583838383
Equity Capital84848485858585858583838383
Other Liabilities -8581,2741,7641,7072,0872,1062,5132,6962,4222,4912,7042,4453,221
Trade Payables6137801,1946047337688427167197791,0611,0321,068
Advance from Customers000018400023241952
Other liability items2454945701,1031,1701,3381,6711,9801,6801,6891,6241,3622,153
Total Liabilities6,1327,1748,2429,26310,34111,98914,50816,45617,58516,44717,10016,24819,476
Fixed Assets -9871,2111,3161,6911,8972,3872,7483,2494,4384,8424,7174,6834,462
Gross Block1,7502,1572,4263,0253,5084,2094,9005,8167,5808,6759,2249,774
Accumulated Depreciation7639461,1101,3341,6111,8222,1512,5663,1423,8334,5065,091
Other Assets -2,9683,8483,6264,5645,3486,8008,3778,8567,4557,9638,0727,2319,145
Trade receivables8981,4201,0601,7701,9442,9644,5624,7123,8904,4054,2043,7184,639
Cash Equivalents537384368668499196659012026712111339
Loans n Advances9111,3311,3217766801,0271,0461,0001,4281,3961,5211,186222
Other asset items-19-23-218885503645135192362863691982,054
Total Assets6,1327,1748,2429,26310,34111,98914,50816,45617,58516,44717,10016,24819,476

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
Cash from Operating Activity -5544861,2532461,4032899061,7862,7471,0161,5392,762
Profit from operations7449921,4411,3282,1402,4383,4732,6562,7652,1931,6612,976
Loans Advances-1195-107-15100000000
Direct taxes-75-176-220-211-394-376-543-479-397-323-174-239
Other operating items0000249-420-74186-12156-31566
Exceptional CF items040000000000
Cash from Investing Activity --1,520-744-1,117-609-425-524-874-2,031-1,9191,430-1,180-546
Fixed assets purchased-456-545-383-696-601-580-872-962-1,084-985-798-653
Fixed assets sold3319302278121288
Investments purchased-2,349-1,373-2,696-1,162-1,370-1,186-3,581-3,595-6,532-4,850-6,062-7,727
Investments sold1,2351,6352,1101,2601,1781,2633,1072,6106,4206,9535,6287,479
Interest received9356574758938973108623482
Dividends received11556031102132000
Loans to subsidiaries-52-448-223-700420131-2-100
Other investing items-6-76-64310-160355-306-852-706184
Cash from Financing Activity -46106-15261-19515228189-693-2,582-304-2,223
Proceeds from shares202310000000
Redemption of debentures000000-50800000
Proceeds from borrowings3246377302,1032,2063,0264,4402,7372,57601650
Repayment of borrowings-196-440-749-1,222-2,116-2,516-3,523-2,122-2,787-614-0-1,705
Interest paid fin-10-18-12-4-63-88-83-69-75-64-71-64
Dividends paid-74-74-123-814-222-271-298-357-407-335-399-400
Other financing items000-5-00000-1,5690-54
Net Cash Flow-920-152-16-302783-8460-56135-13554-8

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2008Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019
ROCE %12%13%18%15%17%20%23%16%12%11%5%12%
Debtor Days9712586123105129171172138165164128
Inventory Turnover5.966.045.535.355.645.876.

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Dr Reddy s Laboratories Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.